✦ LIBER ✦

Early cytogenetic and molecular response during first-line treatment of chronic myeloid leukemia in chronic phase : Long-term implications

✍ Scribed by Alfonso Quintás-Cardama; Jorgé E. Cortes; Hagop M. Kantarjian

Publisher: John Wiley and Sons
Year: 2011
Tongue: English
Weight: 163 KB
Volume: 117
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.26196

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Significance of suboptimal response to i

Significance of suboptimal response to imatinib, as defined by the European LeukemiaNet, in the long-term outcome of patients with early chronic myeloid leukemia in chronic phase

✍ Yesid Alvarado; Hagop Kantarjian; Susan O'Brien; Stefan Faderl; Gautam Borthakur 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 338 KB 👁 1 views

## Abstract ## BACKGROUND: The European LeukemiaNet recommendations for chronic myeloid leukemia (CML) defined a group of patients with suboptimal response to imatinib. The significance of this response was not well defined. ## METHODS: The significance of having had a suboptimal response during

Long-term outcomes in the second-line tr

Long-term outcomes in the second-line treatment of chronic myeloid leukemia : A review of tyrosine kinase inhibitors

✍ Elias Jabbour; Jorge Cortes; Hagop Kantarjian 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 156 KB

Imatinib as the first-line treatment of

Imatinib as the first-line treatment of patients with chronic myeloid leukemia diagnosed in the chronic phase: Can we compare real life data to the results from clinical trials?

✍ Daniela Zackova; Hana Klamova; Ladislav Dusek; Jan Muzik; Katerina Machova Polak 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 286 KB 👁 3 views